# Blood Glycan Biomarkers in Women With Stage IV Breast Cancer

> **NCT00897962** · — · COMPLETED · sponsor: **University of California, Davis** · enrollment: 163 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Healthy Controls
- **OTHER:** Metastatic Breast Cancer
- **OTHER:** Non-cancer medical illness

## Key facts

- **NCT ID:** NCT00897962
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2011-02
- **Final completion:** 2016-01-12
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2018-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897962, "Blood Glycan Biomarkers in Women With Stage IV Breast Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00897962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*